Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome

Fertility and Sterility

Volumn 93, Issue 7, 2010, Pages 2299-2302

  Mashiach, Roy ^a   Amit, Ami ^a   Hasson, Joseph ^a   Amzalzg, Sagi ^a   Almog, Beni ^a   Ben Yosef, Dalit ^a   Lessing, Joseph B ^a   Limor, Rona ^b   Azem, Foad ^a  

^a Department of Obstetrics and Gynecology   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

AMH; Follicular fluid; IVF; PCOS

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; CHEMISTRY; CLINICAL TRIAL; FEMALE INFERTILITY; METABOLISM; METHODOLOGY; OOCYTE; OOCYTE DEVELOPMENT; PHYSIOLOGY; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY RATE; PROGNOSIS;

ADULT; ANTI-MULLERIAN HORMONE; EMBRYONIC DEVELOPMENT; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; INFERTILITY, FEMALE; OOCYTES; OOGENESIS; POLYCYSTIC OVARY SYNDROME; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY RATE; PROGNOSIS;

EID: 77952559281     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.01.125     Document Type: Article

References (17)

1. Fanchin R, Mendez Lozano DH, Frydman N, Gougeon A, di Clemente N, Frydman R, et al. Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab 2007;925:1796-802.
2. Lubin V, Charbonnel B, Bouchard P. The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease. Baillieres Clin Obstet Gynaecol 1998;12:607-18.
3. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T, et al. High incidenceof embryo transfer cancellations in patients with polycys-tic ovarian syndrome. Hum Reprod 1995;10:1962-7.
4. Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanose E, et al. The prognostic value of basal luteinizing hormone: follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques. Hum Reprod 1995;10:2545-9.
5. Fallat ME, Siow Y, Marra M, Cook C, Carrillo A. Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil Steril 1997;67:962-5.
6. Takahashi M, Koide SS, Donahoe PK. Mullerian inhibiting substance as oocyte meiosis inhibitor. Mol Cell Endocrinol 1986;47:225-34.
7. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, et al. Anti-Mullerian hormone inhibits initiationofprimor-dial follicle growthinthe mouse ovary. Endocrinology 2002;143:1076-84.
8. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, et al. Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001;142:4891-9.
9. Ueno S, Kuroda T, Maclaughlin DT, Ragin RC, Manganaro TF, Donahoe PK. Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle. Endocrinology 1989;125:1060-6.
10. Weenen C, Laven JS, von Bergh AR, Cranfield M, Groome NP, Visser J, et al. Anti-Mullerian hormone (AMH) expression pattern in the human ovary: potential implications for initial and cyclic recruitment. Mol Hum Reprod 2004;10:77-83.
11. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients? Br J Obstet Gynecol 2004;111:1248-53.
12. Josso N. Anti-mullerian hormone: hormone or growth factor? Prog Growth Factor Res 1990;2:169-79.
13. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, et al. Anti-Mullerian hormone and anti-Mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995;136: 4951-62.
14. Lyet L, Louis F, Forest MG, Josso N, Behringer RR, Vigier B. Ontogeny of reproductive abnormalities induced by deregulation of anti-Mullerian hormone expression in transgenic mice. Biol Reprod 1995;52:444-54.
15. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999;140: 5789-96.
16. Ben-Yosef D, Yogev L, Hauser R, Yavetz H, Azem F, Yovel I, et al. Tes-ticular sperm retrieval and cryopreservation prior to initiating ovarian stimulation as the first line approach in patients with non-obstructive azoospermia. Hum Reprod 1999;14:1794-801.
17. Long WQ, Ranchin V, Pautier P, Belville C, Denizot P, Cailla H, et al. Detection of minimal levels of serum anti-Mullerian hormone during follow-up ofpatients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 2000;85:540-4.